Category Archives: Health 2.0

Bupa International Releases Health Guides To Hong Kong And Singapore

Bupa International has published two new health guides for expatriates in Hong Kong and Singapore. The guides include information on vaccinations, medical insurance and emergency healthcare.

Expatriate health information is increasingly sought after as a growing number of people relocate to foreign countries for work. Information on healthcare in the East Asian region is particularly needed, as the area’s many booming industries have drawn a large number of foreign workers in recent years.

Expatriates already living in Hong Kong or Singapore and those who are planning to move to either country can access the health guides via the Bupa International website.

The Hong Kong health guide discusses vaccinations and the various infectious diseases that expatriates in Hong Kong may be susceptible to. For those wondering whether to take anti-malarial medicines prior to their move, the health guide explains that this is unnecessary, as the mosquito-transmitted disease is not found in Hong Kong.

However, though malaria is not found in Singapore, the Singapore health guide suggests that expatriates take measures to prevent mosquito bites, as dengue fever and chikungunya have both been reported on the island.

The two health guides also provide information on international health insurance options that expatriates in Singapore and Hong Kong can benefit from and give an overview of the healthcare systems in both city-states, such as the availability of specialist care, the number of hospitals and the nature of primary care.

“Moving and living abroad can be daunting, particularly when it comes to the subject of health,” said Dr Sneh Khemka, medical director for Bupa International. “These health guides will help people to prepare for their move to Singapore or Hong Kong and offer them detailed information about hospital and treatment options there.

“Healthcare systems can vary enormously from one place to another so it’s vital to be prepared for any eventuality before you move or travel abroad. These health guides give an overview of the situation in Singapore and Hong Kong but you should always seek advice from an expert if you have a serious medical condition.”

Bupa International’s website also includes expatriate guides to other countries. The guides offer advice on culture and cost of living in various countries as well as other information such as how people can ship their belongings when relocating to a foreign country.

Via EPR Network
More Healthcare press releases

Bupa Reveals Brits In Denial About Realities Of Too Much Drink

Bupa is warning Brits to face up to the realities of excessive drinking as research reveals that despite having one of the highest rates of alcohol consumption in the world, they are the least likely to want to cut down their intake.

The International Bupa Health Pulse survey which studied over 13,000 people in 12 countries, found that Brits are over a third (41%) more likely to drink alcohol than the international average. They are also twice as likely to describe themselves as ‘regular drinkers’, with almost 1 in 10 (9%) admitting to drinking ‘every day’ – over double the international average.

But despite the proven link between excess* alcohol consumption and a range of life-threatening health conditions, more than 1 in 3 of Brits who drink (38%) say they don’t want to change their behaviour. Internationally, almost 3 in 4 of drinkers have admitted they would like to cut down.

Assistant Medical Director for Bupa, Dr Layla McCay said: “This is a worrying observation which implies that Brits are particularly resistant to change when it comes to drinking habits. Whether that is due to a lack of awareness about alcohol effects or whether we are simply in denial, there is clearly more work to be done to raise awareness of the associated risks and the real impact it can have on lives.

“Excessive drinking carries several health risks, including heart disease, stroke, liver disease, many types of cancer, and even diabetes. Something needs to be done immediately and we need to challenge the social norms – social lives too often revolve around drinking and it is important that we work towards coming up with healthier alternatives. It’s not about total abstinence, but it is about drinking responsibly and being aware of the effects that heavy drinking can have.”

Chief Executive of Drinkaware, Chris Sorek, said: “There is always an excuse to drink but there are plenty of reasons to cut down too. It can be easy to drink more than you intended, by not being aware of the units in your favourite drink or pouring large measures at home. However drinking can affect your sleep patterns, meaning you wake up feeling stressed and tired the next day.

“Regularly drinking over the daily guidelines can lead to more serious health harms including alcohol-related liver disease, which has no warning signs. Alcohol is also the second biggest risk factor for cancer after smoking – responsible for cancer of the breast, liver, bowel and mouth.”

For people worried about the amount they drink Bupa hosts a free alcohol calculator available on its website which calculates how much alcohol an individual consumes and provides alcohol information and support on how to drink less.

Via EPR Network
More Healthcare press releases

Great Ormond Street Hospital Supports Stem Cell Awareness Day

Great Ormond Street Hospital and its research partner, The Institute of Child Health at University College London (UCL), are supporting Stem Cell Awareness Day, with UCL promoting the event with the launch of a new YouTube video featuring Mr Paolo de Coppi and his colleagues.

Mr. de Coppi is Clinical Senior Lecturer in the Surgery Unit at The Institute of Child Health at UCL and carries out stem cell research at Great Ormond Street Hospital. It is hoped the research will result in stem cells being used to repair damaged organs. Mr de Coppi has looked for naturally occurring stem cells in amniotic fluid as a novel solution to some of the serious birth defects he sees. Around 40 per cent of patients at Great Ormond Street Hospital have some form of birth defect.

Mr de Coppi said: “As a surgeon I often see the devastating effects of multiple reconstructive operations aimed at replacing damaged organs. I have therefore focused my research interests on stem cells and tissue engineering, trying to find new ways to treat complex birth defects. I have identified stem cells in the amniotic fluid and found they have the ability to become many different types of cell. Our research aims to find ways of using these cells to repair and replace damaged tissues, so that babies are given the chance of a healthy life from the day they are born.

“The idea is we can create tissues in a test tube using a baby’s own cells, and then implant these at birth. We’re looking at repairing organs like intestines or windpipes. Grown from a child’s own cells, there should be no rejection of tissue.”

The video sees Mr. de Coppi discussing the work he and his colleagues carry out and offering insight into the latest developments relating to his stem cell research and the possibility of deriving cells from amniotic fluid. The full video can be viewed here: http://www.youtube.com/watch?v=qD_V1hqR6SI.

Via EPR Network
More Healthcare press releases

Bupa International Launches New Health Insurance Video

Bupa International has announced the launch of a new video detailing its international private medical insurance (IPMI) product.

Bupa International, a global health insurance provider which gives its members access to more than 7,500 medical facilities around the world, has released the video to show how customers can use its flexible Worldwide Health Options insurance to create a healthcare plan that suits their unique situation and needs. Rather than produce a text-heavy brochure, the company decided to launch a video giving an overview of what the product offers.

The video gives examples of people who have moved abroad following retirement, individuals who travel around the world for work and families who have relocated to another country. By using characters based on real-life stories, the video conveys the flexibility that the product offers and shows customers how they can tailor their international health insurance to fit their own unique situation.

Customers who purchase Bupa’s IPMI can choose as many Worldwide Health Options to add to their cover as they wish, or they can simply stick with the core cover. Options include cover for doctor consultations, medicines, screenings, evacuation and treatment in the United States. Additionally, customers can also apply for cover for pre-existing conditions.

Bupa Worldwide Health Options allows customers to combine modules to create the best solution for each individual or family.

Via EPR Network
More Healthcare press releases

Bupa Puts Real People At The Heart Of New Health Insurance Campaign

Bupa has unveiled its latest TV advertising campaign to promote its new health insurance product, ‘Bupa By You’.

The multi-million pound, integrated, through-the-line campaign launched on 5 September and promotes the adaptable and affordable nature of ‘Bupa By You’.

The direct response TV advert, direct marketing and digital advertising have all been created by OgilvyOne.

Bupa By You‘ is a natural evolution of the brand’s ‘Helping You Find Healthy’ campaign launched earlier this year which demonstrated that healthy means different things to different people. The product meets this ambition by providing customers with the ability to personalise their insurance cover to best reflect their individual health needs, priorities and budget.

The campaign focuses on real people in real situations revealing them to be doing something that isn’t initially expected. This helps to demonstrate that ‘Bupa By You’ is adaptable and Bupa doesn’t make assumptions about its customers health insurance needs.

“‘Bupa By You’ is proof that health insurance doesn’t need to be one-size-fits-all,” commented Sue Moore, marketing and customer development director at Bupa Health & Wellbeing. “We have put the customer at the heart of the decision making process and the adaptable nature of the product reflects how we have listened to their needs.”

Annette King, Chief Executive, OgilvyOne, added: “This campaign demonstrates how Bupa is doing things differently – providing an adaptable product that meets individual customer needs. Our multi-platform approach allows us to communicate with customers on a very personal level.”

Media buying was undertaken by Carat.

Further information about Bupa By You can be found on Bupa’s website, with the new TV advert available on Bupa’s YouTube channel.The product is available for purchase by phone now and online from late September via www.bupa.co.uk/byyou

Via EPR Network
More Healthcare press releases

Great Ormond Street Hospital Patients Take Part In Duchenne Muscular Dystrophy Clinical Trial

Great Ormond Street Hospital has announced that a team led by scientists at its research partner, UCL Institute of Child Health (ICH), funded by the Medical Research Council (MRC) and AVI BioPharma, have made an important breakthrough in the development of a treatment for Duchenne Muscular Dystrophy (DMD).

Together with the MDEX Consortium, chaired by the ICH’s Professor Francesco Muntoni, the group showed that a gene based drug treatment was effective in restoring the dystrophin protein, missing in sufferers of DMD in seven out of 19 trial participants.

The results of the clinical trial will be published in The Lancet, a world leading general medical journal.

DMD is a devastating and life limiting condition, affecting one in 3,500 male births in the general population, with around 100 cases diagnosed in the UK each year.

Three of the participants in the higher dose cohort showed dystrophin levels exceeding 18 per cent of those found in normal muscle.

Thirteen per cent of boys with DMD could be treated with this specific ‘antisense’ gene therapy, the largest group by a single antisense. Overall, scientists say this approach could work for at least 70 per cent of DMD sufferers.

DMD causes progressive muscle weakness due to the breakdown and loss of muscle cells. Patients lack a single important protein in their muscle fibres called dystrophin. By ages eight to 12 years boys become unable to walk, and by their late teens or early twenties the condition can become severe enough to limit life expectancy.

In this clinical trial of 19 patients, study participants aged five to 15 at Great Ormond Street Hospital and the Royal Victoria Infirmary, Newcastle, were given weekly doses of the drug, AVI-4658. The drug had already been tested for safety and efficacy by the MDEX Consortium and AVI Biopharma in an earlier phase of the study.

Francesco Muntoni, professor of paediatric neurology at the ICH, said: “These are very exciting results that prove the case for an even more detailed look at this genetic therapy. I’ve worked with patients with DMD for many years and this is the first time we can say with confidence that we’ve made a significant breakthrough towards finding a targeted treatment.

“Importantly, the study drug was extremely well tolerated, with no appreciable side effects detected during the study period in any of the boys. If our strategy shows continued success, this therapy could substantially reduce muscle damage in affected boys with DMD, improve the quality of life for DMD patients, their mobility and the way their condition is managed as they get older.”

Professor Max Parmar, director of the MRC Clinical Trials Unit, said: “A large proportion of new drugs do not make it past the phase II stage of testing reached here, so there is real excitement that this treatment could work.

Brothers Jack, 11, and Tom, 8 were enrolled on the trial. Both have DMD with a deletion from 45-50. Their mum, Claire, said: “Jack and Tom were placed on a DMD genetic registry, co-ordinated by Action Duchenne, which is how we were approached about the clinical trial at Great Ormond Street Hospital.

“The boys were on the trial for 12 weeks between 2009 and 2010. Our whole family noticed a marked difference in both of their quality of life and mobility over that period. We feel that it helped prolong Jack’s mobility and that Tom has been considerably less fatigued.”

Via EPR Network
More Healthcare press releases

Bupa Care Homes Roll Out the Red Carpet for Cannes Film Festival

Bupa care homes residents across the UK rolled out the red carpet as they added a local twist to the 2011 Cannes Film Festival.

Altogether over 250 care homes, including dementia care homes, transformed rooms into in-house movie theatres and showed classic films, with staff dressing up as famous film stars, such as Charlie Chaplin, and ushers to bring the festival to life. Care home residents were also served popcorn and ice cream during the film intervals. The homes were also joined by entertainers to serenade the residents with their favourite show tunes.

Each home was provided with a selection of iconic movie star photographs in order to set the scene.

Penny Leng, Bupa Care Homes’ national activities manager, said: “Our residential and care home staff really went the extra mile to recreate the cinema experience so residents had the chance to feel part of the action.

“It was a fantastic way to appreciate the glitz and glamour of the Cannes Film Festival, as well as offering a great opportunity for our residents to reminisce and talk about their favourite legends of the silver screen.

“Many of our residents remember the bygone era of when going to the cinema was a really thrilling experience, and we’ve thoroughly enjoyed bringing that sense of excitement to life in our homes.”

This year marked the 64th Cannes Film Festival, which took place from 11-22 May. Known as the world’s oldest and most esteemed showcase for European films, movie stars and producers flock to the festival each year to launch their new films.

Via EPR Network
More Healthcare press releases

Bupa Awards Free Places in Bupa Junior Great Manchester Run

Bupa awarded ten free places in the Bupa Junior Great Manchester Run to pupils from Moorgate Primary School in Bolton, Lancashire.

Ten pupils from the school, situated in close proximity to Bupa’s Mill View Residential and Nursing Home and Nursing Home were offered the chance to tackle the 2.5km course for free.

Bupa awarded the ten free running places to the school, to encourage the children to exercise, after members of staff from the Bupa residential and nursing home delivered Activ-eat, Bupa’s initiative which teaches children the benefits of healthy eating through fun and memorable activities.

The school gratefully snapped up the free places and all funds raised were donated to Leukaemia and Lymphoma Research.

This year Bupa also offered free running places to the relatives of all its care home residents. In addition, four staff members from Bupa Care Services took part as runners and one as a volunteer.

Sue Kilby, activity coordinator at Bupa’s Mill View Residential and Nursing Home, said: “We have been delivering Activ-eat to the children from Moorgate Primary School for some time and they are always excited about getting involved and learning more about healthy eating. I am so pleased that the children decided to take part in the Bupa Junior Great Manchester Run, and they all did brilliantly on the day.”

Siobhan Drane, Bupa’s community affairs consultant, commented: “As a healthcare company, Bupa is keen to help tackle the issue of child obesity and promote nutrition and exercise. I am delighted that the children at Moorgate wanted to get involved in the run, and it is a great addition to the lessons learnt on our Activ-eat programme.”

Via EPR Network
More Healthcare press releases

Enabling microRNA Discoveries – 250th Peer-Reviewed Publication Made Possible By µparaflo Custom Microarray Technology

LC Sciences, a life sciences company leading the development of innovative microRNA (miRNA) analysis and discovery technologies, announced today the publication of over 250 peer-reviewed studies using the company’s microarray service for analyzing miRNA expression profiles. These studies, by leading researchers in the field, represent significant steps toward realizing these small regulatory RNA’s potential as biomarkers and therapeutic targets.

MiRNAs have proven to be an extremely important part of the gene expression regulation mechanism of a wide variety of cellular processes. This is evident in the amount of relevant findings by LC Sciences’ customers being translated into published reports and the diverse range of study areas that these publications encompass: cancer research, neuroscience, cardiovascular research, reproductive biology, plant science, microbiology, immunology and stem cell research. LC Sciences’ miRNA profiling service, powered by its µParaflo® custom microarray technology, provides quick, reliable, fully analyzed datasets enabling researchers to immediately move forward with groundbreaking research.

The miRNA field is still nascent, and it is advancing rapidly. The race to discovery has produced a continuous stream of new miRNA sequences as well as routine revisions of inaccurate or incomplete sequences. This fluidity has caused many microarrays with static content to fall away and has fueled reports of the wholesale replacement of microarrays by new methods such as RNA-Seq. But the nimble, customizable format of the µParaflo® array has given it staying power, not only by enabling it to keep current with all known miRNAs, but also by making use of data generated by RNA-Seq. These custom arrays have benefited from RNA-sequencing generating novel content that other arrays are unable to capture and take advantage of.

The 250th study, entitled “Wolbachia uses host microRNAs to manipulate host gene expression and facilitate colonization of the dengue vector Aedes aegypti.” appeared in the May 31st issue of PNAS and was one of a group of articles published recently by LC Sciences’ customers describing microarray expression analysis of miRNAs recently discovered through RNA Sequencing.

Via EPR Network
More Healthcare press releases

Bupa Announces Unhealthy Brits Cost Country Around £17.7 Billion a Year

Bupa has revealed that unhealthy Brits are costing the NHS, employers and themselves £17.7 billion every year through their lifestyle choices, according to new research from the leading international healthcare group. This figure could rise to almost £33bn a year by 2025 if current health trends continue.

The study calculated immediate and long-term potential savings to individuals and public purses if obesity rates stop rising; the 26 per cent of smokers who attempt to quit each year are successful; and excessive drinkers bring their intake down to recommended levels.

According to the findings, making healthier lifestyle choices such as quitting smoking, reducing alcohol intake and becoming more active can have an immediate impact on people’s wallets. Signing up for health cash plans could also help save money if any medical problems did arise, which could be found by undergoing health assessments such as a liver check or a coronary health check.

By 2025, if healthier lifestyles are adopted the total savings made by individuals alone across the UK could amount to £22 billion a year, two thirds of the potential annual savings of £33 billion. The £22 billion comes from savings of £5 billion and£3.9 billion through reduced expenditure on alcohol and cigarettes respectively and£7.4 billion saved in additional earning potential due to increased life expectancy from quitting smoking. Individuals could also save £1.7 billion through increased employment and £3.9 billion through increased earning potential due to a fall in obesity levels.

The findings of the report also outline the long-term financial implications of healthier lifestyles to employers and the NHS, which make up the remainder of the £33 billion figure.

Dr Johann Carinus, assistant medical director, Bupa Health and Wellbeing, said:
“This study not only reveals the true cost to the nation of unhealthy lifestyle choices but it also highlights the considerable savings to the public purse which could be achieved through individual commitments to health improvement.

“Data released earlier this year from the Bupa ‘Health Age’ report showed that almost 70 per cent of people in the UK wanted to make a positive change to improve their health in 2011. While ultimately it’s up to individuals to make healthy lifestyle choices, there is a huge opportunity for healthcare providers and employers to play their part in empowering individuals to live more healthily. The benefits for everyone are clear.”

To coincide with the new findings, Bupa is launching the “Bupa Health Pledge” campaign, calling on the public to make a Pledge to achieve their health goals – whether it’s to quit smoking, cut down on alcohol, eat more healthily or do more exercise. Bupa has launched a simple tool that allows members of the public to track their progress on a specific Health Pledge and access information, free expert advice and support needed to make the desired change, all on its Facebook page.

As Bupa’s own Health Pledge, the healthcare company is also committing to donate £1 to the British Heart Foundation for everyone who signs up to a Pledge.

Via EPR Network
More Healthcare press releases

Innovators in Health Care Meeting at HealthCamp Florida on July 30, 2011

The inaugural meeting of HealthCamp Florida will be held in Tampa, Florida on July 30, 2011. It will be held on Saturday, July 30 at Kforce in Tampa (1001 E. Palm Ave., Tampa, FL 33605). This is the inaugural event for HealthCamp Florida and the theme is ‘The remarkable innovations that are transforming healthcare.’ The focus will be on technology, policy and process areas and it is expected that these three areas will help to cross-pollinate thoughts, speakers and attendees and inform the discussions.

HealthCamps have been held in a number of other cities, including Boston, Philadelphia, San Francisco and other locations. HealthCamp will be similar to a BarCamp type of unconference but the attendees and speakers will represent a wide variety of people, industries and advocates focused around health care topics. These events have become popular because they involve interesting, high-energy people talking about interesting things.

One of the goals of HealthCamp Florida is to raise awareness of the remarkable innovators and innovations available right here in Florida. The event will bring together interesting people who might otherwise not meet at their own individual industry meetings. This will allow them to share, collaborate, learn and inspire. Some of the extraordinary innovators who are on the cutting edge of health care innovation have committed to attending the event and speaking. They will cover topics ranging from a new non-invasive medical device that provides more accurate predictions of heart risk, to iPhone and iPad apps for health care, to a neural communications device to help the brain communicate with prosthetic limbs, and to a new way to manage patient data and more. The website is www.healthcampflorida.org.

About HealthCamp Florida: HealthCamp Florida is part of the HealthCamp group of events and is designed to look at innovations in HealthCare in general and, focus on people, companies and innovations in Florida.

Via EPR Network
More Healthcare press releases

Bupa Care Homes ‘Grow Their Own’ For Community Initiative

Bupa care homes’ residents have their watering cans at the ready as they prepare to ‘grow their own’ for ‘Community Crops’.

‘Community Crops’ is a Bupa care homes initiative which promotes the health benefits associated with gardening and growing your own fruit and veg.

The project is being supported by young people involved with The Prince’s Trust, who are linking up with Bupa homes, including nursing care homes, across the UK to help sow and grow the crops.

Residents have also been inviting local schools and community groups to lend a hand with planting and start their own vegetable plots.

Caroline Davy, Bupa’s community affairs assistant, said: “This is a great way for our residents to appreciate the fresh air, stay active and get a real sense of achievement by tending to the crops and watching them grow.

“For our residents who were keen gardeners before they joined us, ‘Community Crops’ offers a great opportunity to get back involved, but it also helps minds as well as bodies. Particularly for our residents receiving dementia care, sharing stories about ‘dig for victory’ and the tradition of growing your own are excellent memory triggers to aid connections with the past.”

Helen Thurston, from The Prince’s Trust added: “‘The Community Crops’ campaign is a fantastic project which provides our Prince’s Trust XL club members with the opportunity to get involved with their local community. It enables young people to engage in a positive way with a different generation and learn about the importance of healthy eating.”

Altogether, the Community Crops campaign has taken root in gardens and greenhouses in over 300 care homes across the UK.

Via EPR Network
More Healthcare press releases

Bupa Care Home Residents Set To ‘Get Into Reading’ With Special Reading Aloud Groups

Bupa has joined forces with charity The Reader Organisation to encourage its care home residents to ‘get into reading’ with special reading aloud groups.

The ‘Get into Reading’ groups will be piloted in eight Bupa care homes for six months from April 2011. Get into Reading aims to bring the benefits of reading aloud and of social interaction to people in health and care environments, such as residential homes or homes offering nursing care.

Each group will enjoy shared reading led by a project worker from The Reader Organisation for an hour each week. Members will discuss what’s being read as they go along, and relatives, staff and members of the local community will be welcome to join in as well. Studies show that literature can have a healing or therapeutic effect on readers, helping them to identify with characters and situations in books or to be ‘taken out of themselves’ by the story.

The Reader Organisation’s experience has shown that short stories and poetry have proved most beneficial for people with dementia. The project will ensure that Bupa care home staff members will be trained to deliver read-aloud groups themselves. Following assessment of the pilot, Bupa plans to offer groups to its 305 homes nationally as part of its industry-leading Activities programme.

Siobhan Drane, Bupa Care Services community manager said: “We are really pleased to be working with The Reader Organisation to deliver ‘Get into Reading’. We hope that these reading aloud groups will reignite a passion for literature in our residents, spark a new interest or offer an opportunity for reminiscence. We believe our residents will benefit from the positive effect literature can have on wellbeing.”

Via EPR Network
More Healthcare press releases

Bupa Care Homes Hold Communi-tea Week Celebrations

Bupa has held Communi-tea Week events in its care homes to help tackle loneliness in older people.

Residents of Bupa care homes throughout the UK have brewed up some community spirit by inviting older people to join them for a friendly cup of tea.

Altogether, over 300 care homes, including residential care and nursing care homes, hosted special afternoon tea parties to mark Communi-tea Week, a nationwide campaign which aimed to use tea-related social activities to help tackle the problems of isolation and loneliness in older people.

Worrying statistics demonstrate the size of the isolation problem in the UK, with over 1 million (11%) of people aged 65 or over saying they are always or often feel lonely. Nearly half of all older people believe that the television is their main form of company and 17% of older people have less than weekly contact with family, friends and neighbours*.

Siobhan Drane, Bupa’s community affairs manager, deemed the week a great success:
“Communi-tea Week is a great way of highlighting the support networks that are available in local communities, as well as raising awareness of the serious issues facing older people today. Everyone put on the kettle and contacted someone they thought may need their spirits lifting – a cup of tea is the perfect way to reach out and make a difference.”

As well as organising tea-related social events, from tea-tasting sessions to tea dances, Bupa care homes urged others to help by inviting older people living on their own to join them for a cuppa, whether it be a neighbour or friend.

Via EPR Network
More Healthcare press releases

Will the Catholic Church & the U.S. Courts Embrace Advanced Cell Technologies “Embryo-Safe” Technique Using Embryonic Stem Cells?

Advanced Cell Technology with laboratory facilities in Marlborough Massachusetts has pioneered a solution to the ethical, moral & legal debate raging in regards to protection of a human embryo. ACT has developed the “single-blastomere” technique. Patent Number 7,893,315 a non-destructive alternative for deriving human embryonic stem cell (hESC) lines.

This achievement in Regenerative medicine is a ground breaking feat for both Catholic and U.S. law.
• The 1995 encyclical The Gospel of Life, of which Pope John Paul II wrote: “Human embryos obtained in vitro are human beings and are subjects with rights; their dignity and right to life must be respected from the first moment of their existence. It is immoral to produce human embryos destined to be exploited as disposable ‘biological material'” (1,5 )
• The Dickey Amendment (also known as the Dickey-Wicker Amendment) is the name of an appropriation bill rider attached to a bill passed by United States Congress in 1995, and signed by former President Bill Clinton, which prohibits the Department of Health and Human Services (HHS) from using appropriated funds for the creation of human embryos for research purposes or for research in which human embryos are destroyed.

The single-blastomere technology uses a one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential. The stem cells generated using this approach are healthy, completely normal, and differentiate into all the cell types of the human The safety record for one-cell biopsy as part of PGD now has a 15-year track record, and is carried out routinely as part of IVF processes around the world. ACT’s technique of protecting the human embryo from harm can be expounded to the smallest blood transfusion in the world. As does a human being give millions of blood cells in a pint of blood so does ACT’s “single blastomere” process take but “one cell” from a 2 day old embryo. As the blood removed from a human donor “regenerate” the removed pint of blood so does the human embryo “regenerate” the one cell. Both of these procedures leave the human body & two day old embryo healthy. Both procedures are similar in that they both provide life saving material to those whom need them most to due to disease and other aliments of a medical nature.

Via EPR Network
More Healthcare press releases

Side by side comparison of Advanced Cell Technology & Geron Corporation

Regenerative medicine is a highly complicated and vastly misunderstood science. Investor Stem Cell is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible advancements unfolding in the regenerative medicine sector. A quantum leap in health care is upon the world. Will you profit from this emerging sector & help bring cures to millions? Find out now what the street thinks at www.investorstemcell.com.

Side by side comparison of Advanced Cell Technology & Geron Corporation:

Geron Corporation (NASDAQ:GERN), Approved by the FDA to use human embryonic stem cell (hESC) treatments to treat spinal cord injuries. The research Goliath is a well-funded machine employing the top minds in the world working on everything from mid-stage oncology trials to promising (hESC) drugs for spinal cord injuries, heart disease & cancer.

Snap shot of Goliath: Geron Corpoartion-(NASDAQ:GERN)-
• Seven oncology Phase 2 trials currently underway, and has several big Pharma joint venture agreements in oncology animal and human trials
• Five hESC areas of investigation underway. GRNOPC1 is the lead candidate. Geron destroys the human embryo through its (hESC) R&D, of which the company uses the blastocyst embryo formation at day five after fertilization from IVF clinics
• Cash, restricted cash, cash equivalents and marketable securities: $221,274.000.00
• Total operating expenses in 2010: $114,730,000.00
• 175 employees; over 100 hold PhD or MD degrees
• Geron Corporation was founded in 1990 and is based in Menlo Park, California
• Trades on the NASDAQ providing liquidity & large institutional investors
• Corporate financial statements:http://www.geron.com/investors/reports/GeronAnnualReport2010.pdf

Advanced Cell Technology not too long ago was the predominant leader in the field of regenerative medicine. It fell from that distinction in part due to executive management hubris and ultimately the credit crisis in mid-2008. ACT was able to resurrect itself from near bankruptcy in June 2008 and now has the distinction of holding two out of the three FDA approved (hESC) trials. ACT is led by a competent executive management team and employs several of the most predominant regenerative researcher(s) in the world.

Snap shot of David: Advanced Cell Technology-(OTC:ACTC)-
• Retinal Pigment Epithelial Cell Program is their lead program-(HESC) trials for both SMD/AMD are expected to start in week(s) Jules Stein Eye Institute at the University of California, Los Angeles (UCLA ) will conduct the 2 (hESC) trials for Stargardt’s Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (AMD)
• Filed a European Clinical Trial Application for Phase 1/2 study using (hESC) to treat macular degeneration
• Issued a broad patent for hESC-derived RPE cells in China
• Seeking funding & joint venture partner for Myoblast program for the treatment of cardiovascular disease Phase 2 approved by the FDA
• Joint ventured with Korean medical giant CHA to form “Stem Cell & Regenerative Medicine International” (SCRMI). This partnership expected to file an investigational new drug application (IND) with the FDA in Q-4 of this year. CHA biotech is waiting for final approval from the Korea Food and Drug Administration for (hESC) trial for AMD
• Issued patent on its “single-blastomere” technique. Patent Number 7,893,315 broadly covers ACT’s proprietary single-blastomere technology that provides a non-destructive alternative for deriving hESC lines. This “Embryo-Safe” one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential
• 22 full-time employees, six hold PhD or MD degrees-Formed in 1994, HQ in Menlo Park, California with laboratory facilities in Marlborough, MA
• Total operating expenses in 2010: $22,044,701
• Cash, restricted cash, cash equivalents and marketable securities: $34,889,409
• Trades on the OTC:BB ACTC is a Sarbanes–Oxley Act SEC reporter
• Corporate financial statements: http://www.sec.gov/Archives/edgar/data/11...

Via EPR Network
More Healthcare press releases

New Website Dedicated To Stem Cell Investors

Investor Stem Cell (http://www.investorstemcell.com) is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible medical advancements taking place in the regenerative medicine sector. Scientists are using stem cells both (hESC) and (iPSC) in hopes of easing the suffering of hundreds of millions of people world wide.

Our society is on the verge of a quantum leap moment in time thanks to regenerative medicine.

Regenerative medicine and Stem Cell research:

Utter those words at your next dinner party or casual gathering of friends and family. You will receive a concoction of half-truth’s and out right fallacy responses. Stem Cell research conjures images of futuristic Star–Trek like preservation chambers, human looking ears protruding oddly from the backs of mice, or worse yet an image of a late term fetus. Nothing could be farther from the truth when entering the reality of Regenerative medicine.

Never before has this area of research been more exciting and promising than right now. There is a medical revolution brewing, and like any revolution, there are those who want to suppress this uprising for continued personal and ideological gains. If we were to take all the major advances in the past 500 years of human medical history and multiply its effect by 10 fold it still would not compare to the paradigm shift in health care delivery that the world may witness in this decade using stem cells. Imagine that an $800,000 heart transplant is no longer needed and that instead the same money spent on one patient can now be stretched out to treat 20 patients who are needing a heart transplant. Is this what Regenerative medicine has in the offing? Only time will tell. Our healthcare system could very well be on the verge of a quantum leap moment thanks to regenerative medicine.

The Food and Drug Administration (FDA) authorized 3 trials using human embryonic stem cells (hESC) in late 2010. Validation of hESC research efforts and the culmination of billions spent on research are coming to fruition. FDA validation for the treatments of spinal cord injury and age related macular degeneration is expected in 2011. It may be the shot heard around the world event sometime in late Q-4 2011 for the Regenerative medicine sector.

Via EPR Network
More Healthcare press releases

Bupa Announces Results of Customer Satisfaction Survey

Bupa has announced the results of this year’s Bupa Care Services Customer Satisfaction Survey.

74% of Bupa care home residents rate the overall standard of care at their Bupa care homes ‘excellent’ and/or ‘very good’. The results came from the annual independent survey of residents and relatives which has been running for 12 years.

This is the eighth consecutive year the overall customer satisfaction score has risen.

In addition to this 94% of residents rated Bupa’s quality of nursing care and other care as excellent or very good, 91% of residents rated Bupa’s staff as excellent or very good for being treated as individuals and 91% of residents rated Bupa’s staff as understanding the residents needs as excellent or very good.

Oliver Thomas, director of Bupa’s UK Care Homes, said: “Residents and their families are in the best position to judge our care and I am delighted to see such a positive response from them.

“Our overall customer satisfaction score has risen for eight consecutive years since the introduction of our Personal Best development programme, which encourages staff to recognise the individuals we care for and to go that extra mile.

“This is a tribute to all our committed care home staff and the excellent care that they provide. Their efforts are clearly being acknowledged by residents.”

The Bupa Care Services Customer Satisfaction Survey is commissioned annually and carried out independently by Deighton Consultants.

All residents at Bupa care homes are offered the opportunity to fill in a questionnaire each year, which allows them to feedback and comment on their overall care, staff, the buildings and grounds, their room, being treated as an individual, communal rooms, the food and their activities. Relatives of residents with dementia are also offered the opportunity to feedback on these aspects including dementia care.

Via EPR Network
More Healthcare press releases

Bupa Boosts Cancer Cover

In an industry first, Bupa, the leading international healthcare group, has announced plans to improve the quality of its cancer cover by no longer selling corporate health insurance schemes which feature overall cost or time limits for cancer treatment.

Cancer treatment costs increased sharply in 2005 and 2006 due to the introduction of new drugs. In response to the concerns this caused about rising costs, the health insurance market developed financial benefit caps and time limits to restrict financial exposure for client businesses.

However, experience has shown that these limits mean that patients who claim on their policies can be left vulnerable at critical points in their treatment.

Once employees reach their benefit ceiling they face the possibility of having to change their treatment mid-stream. The varying cost of cancer drugs also makes it very difficult for patients to make informed choices about their treatment path, and its likely cost, at the point of diagnosis.

Dr Natalie-Jane Macdonald, managing director, Bupa Health and Wellbeing explained: “We work closely with our clients to help them to provide their employees with the best quality healthcare at a sustainable affordable cost, and this remains a priority for us. We have developed better, fairer ways of controlling healthcare costs without compromising the experience and outcomes of patients at a difficult time in their lives.”

In 2010 Bupa spent £18m on drugs that are not widely available elsewhere and it routinely funds cancer treatments that are approved by the European Medicines Agency. Bupa also makes prompt decisions to pay for experimental drugs when clinically appropriate.

Via EPR Network
More Healthcare press releases

Bupa Reveals the Average Brit is Cutting Life Expectancy by 12 Years

Bupa has revealed that the average Brit is at risk of cutting more than a decade off their life through unhealthy lifestyle habits. This is according to new research from the leading international healthcare group.

The Bupa study assessed lifestyle behaviours such as smoking, alcohol intake, diet and exercise as well as other factors, in nearly 5,000 adults across Britain to calculate the nation’s average Health Age, which is the impact that lifestyles are having on Briton’s life expectancy.

The results showed that on average, Brits have a Health Age 12 years older than if they adopted healthy habits. Worryingly, more than one in eight people are at risk of cutting their life short by 20 years or more.

Being married or in a long-term relationship has a positive impact on Health Age across all age groups, increasing potential life expectancy by more than four years.

Women in their 50s had some of the unhealthiest behaviours, being more inactive and overweight than women in other age groups. Men in their 50s and 60s were also more inactive and overweight than other men.

Dr Annabel Bentley, medical director, Bupa Health and Wellbeing said: “We all know that bad habits such as smoking and drinking too much alcohol damage our health but these findings show the real impact of our habits and the number of years we’re knocking off our lives unnecessarily.

“But it’s never too late to make a change for the better. Whether you’re in your twenties or in your seventies, you could add years to your life by making lifestyle changes.”

A link between happiness and healthiness also showed that nine out of ten of the healthiest people (91% – those within 6 years of their ideal health age) thought they were as happy as or happier than other people, while less than 7 in 10 of the least healthy people (66% – 25 or more years away from their ideal health age) thought so.

Even making one change to lifestyle can have a significant impact on life expectancy. For example, a 25 year old female who drinks 20 units a week (ten standard glasses of wine), could add up to three years to her life by drinking three fewer glasses of wine a week.

Users can discover their health age by completing the health age calculator at bupa.co.uk/findhealthy.

Via EPR Network
More Healthcare press releases